共 50 条
- [4] Belimumab (Benlysta) for Systemic Lupus Erythematosus MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2011, 53 (1366): : 45 - 46
- [6] Lupus: Phase III Trial Results with Blisibimod is well tolerated NEPHROLOGE, 2016, 11 (01): : 2 - 2
- [10] Positive results for anifrolumab in phase III SLE trial Nature Reviews Rheumatology, 2020, 16 : 125 - 125